Cardiac autonomic functioning is impaired among allogeneic hematopoietic stem cell transplantation survivors: a

G Deuring1,2, A Kiss1, J P Halter3

  • 1Department of Psychosomatic Medicine, Division of Internal Medicine, University Hospital Basel, Basel, Switzerland.

Insights

Cardiac autonomic functioning is impaired in allogeneic hematopoietic stem cell transplant survivors, showing higher heart rates and lower parasympathetic control, especially with severe fatigue. This impacts long-term outcomes.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Autonomic Neuroscience

Background:

  • Healthy cardiac autonomic functioning (CAF) is crucial for maintaining homeostasis.
  • Impaired CAF is linked to increased morbidity and mortality.
  • Understanding CAF post-allogeneic hematopoietic stem cell transplantation (allo-HSCT) is vital for long-term survivor care.

Purpose of the Study:

  • To investigate cardiac autonomic functioning (CAF) in survivors of allo-HSCT.
  • To compare CAF between allo-HSCT survivors and healthy controls.
  • To examine the relationship between fatigue, fitness, and CAF in allo-HSCT survivors.

Main Methods:

  • Ambulatory assessment of heart rate (HR) and respiratory sinus arrhythmia (RSA) in 104 allo-HSCT survivors and 45 controls.
  • Laboratory and 12-hour naturalistic measurements of HR and RSA.
  • Assessment of cancer-related fatigue and physical fitness (VO2max).

Main Results:

  • Allo-HSCT survivors exhibited greater fatigue and lower fitness compared to controls.
  • Patients showed persistently higher average HR and lower mean RSA magnitude in both lab and real-life settings.
  • Severely fatigued patients had higher HR and lower parasympathetic cardiac control, independent of fitness.

Conclusions:

  • Allo-HSCT survivors demonstrate significant impairments in cardiac autonomic functioning.
  • Fatigue is strongly associated with reduced parasympathetic cardiac control in this population.
  • These findings have implications for predicting treatment outcomes and guiding post-transplant care strategies.

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...